Biosergen AB (OSTO:BIOSGN) Total Liabilities : kr4.81 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Biosergen AB Total Liabilities?

Biosergen AB's Total Liabilities for the quarter that ended in Dec. 2024 was kr4.81 Mil.

Biosergen AB's quarterly Total Liabilities declined from Jun. 2024 (kr3.72 Mil) to Sep. 2024 (kr2.86 Mil) but then increased from Sep. 2024 (kr2.86 Mil) to Dec. 2024 (kr4.81 Mil).

Biosergen AB's annual Total Liabilities declined from Dec. 2022 (kr11.00 Mil) to Dec. 2023 (kr5.09 Mil) and declined from Dec. 2023 (kr5.09 Mil) to Dec. 2024 (kr4.81 Mil).

Biosergen AB Total Liabilities Historical Data

The historical data trend for Biosergen AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosergen AB Total Liabilities Chart

Biosergen AB Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

15.72

9.25

11.00

5.09

4.81

Biosergen AB Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial												5.09	4.08	3.72	2.86	4.81

Biosergen AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Biosergen AB's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	4.814	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	4.81

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	53.022	-	48.208
	=	4.81

Biosergen AB's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	4.814	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	4.81

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	53.022	-	48.208
	=	4.81

Biosergen AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Biosergen AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosergen AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosergen AB (OSTO:BIOSGN) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Fogdevreten 2, Solna, SWE, 17165

Website

https://www.biosergen.net

Biosergen AB is a biotech company developing innovative antifungal drugs based on latest biopharmaceutical research and development from laboratory facilities in Trondheim, Norway, and several other places worldwide. The company is developing BSG005, a potentially disruptive antifungal drug, which has demonstrated significant safety and potency advantages over competing antifungals.

Biosergen AB Headlines

No Headlines